Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study

Pinkal Desai, MDMPH, Samuel Handelman, PhD, Alan Wu, MPH, Paul J Christos, Dr.P.H., M.S., Sangmin Lee, MD, Michael B. Samuel, MD, Ellen K. Ritchie, MD, Monica L. Guzman, PhD, Rebecca Jackson, Duane C. Hassane, PhD, Joann Manson, Alexander Reiner, MD, Michael S. Simon, MDMPH, Gail J. Roboz, MD

Blood (2019) 134 (Supplement_1): 1199.

https://doi.org/10.1182/blood-2019-131862

Published: 2019

Journal Articles

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Blood (2019) 134 (Supplement_1): 2843.

https://doi.org/10.1182/blood-2019-126661

Published: 2019

Journal Articles

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma

Blood (2019) 133 (10): 1130–1139.

https://doi.org/10.1182/blood-2018-07-862607

Published: 2019

Includes: Supplemental data

Journal Articles

Chronic Myeloid Leukemia Incidence Based Estimates of Hematopoietic Stem Cell Numbers per Person

Tomas Radivoyevitch, Brian P. Hobbs, PhD, Yasunobu Nagata, Jacob Scott, MD, Asha Kallianpour, MD, Takuya Sakaguchi, PhD, Jaroslaw P. Maciejewski, Yasushi Miyazaki, MD PhD

Blood (2018) 132 (Supplement 1): 5441.

https://doi.org/10.1182/blood-2018-99-119583

Published: 2018

Journal Articles

Cancer in Heterozygote Carriers of Fanconi Anemia Genes

Blanche P. Alter, MD MPH, Neelam Giri, MD, Lisa James McReynolds, MD PhD, Philip S. Rosenberg, PhD

Blood (2018) 132 (Supplement 1): 3868.

https://doi.org/10.1182/blood-2018-99-116458

Published: 2018

Journal Articles

PALB2 Mutational Status in Haematopoeitic Malignancies - a Potential Therapeutic Target?

Ceri Oldreive, PhD BSc, Tatjana Stankovic, MD PhD, Philip J Byrd, PhD, Grant S Stewart, PhD, Anna Smith, Alexander J Taylor, Peggy Fooks, Robert Horsley, James I Last, Dragana Janic, MD PhD, Lidija Dokmanovic, MD PhD, A. Malcolm R Taylor

Blood (2016) 128 (22): 2726.

https://doi.org/10.1182/blood.V128.22.2726.2726

Published: 2016

Journal Articles

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

Smita Bhatia, MD, MPH, Cor van den Bos, MD, PhD, Can-Lan Sun, PhD, Jillian Birch, MD, Lisa Diller, MD, Kimberley Dilley, MD, MPH, FAAP, Jill Ginsberg, Laura Therese Martin, MD, Rajaram Nagarajan, MD, MS, Joseph P. Neglia, MD, MPH, Monica Terenziani, MD, David Tishler, MD, Anna T Meadows, MD, Leslie L. Robison, PhD, MPH, Odile Oberlin, MD, Jennifer P. Berano Teh, MD

Blood (2013) 122 (21): 2992.

https://doi.org/10.1182/blood.V122.21.2992.2992

Published: 2013

Journal Articles

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Blood (2012) 120 (21): 2823.

https://doi.org/10.1182/blood.V120.21.2823.2823

Published: 2012

Journal Articles

Low Testosterone Levels Are Associated with Shorter Progression Free Survival in Multiple Myeloma

Heather McDonagh, B.A., William Falk, B.S., Anissa Bingman, M.S., Susan Geyer, PhD, Don M. Benson, Jr., MD, PhD, Yvonne A Efebera, M.D., Craig C. Hofmeister, MD

Blood (2012) 120 (21): 4978.

https://doi.org/10.1182/blood.V120.21.4978.4978

Published: 2012

Journal Articles

FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma

Yussanne P. Ma, Flora E. van Leeuwen, Rosie Cooke, Annegien Broeks, Victor Enciso-Mora, Bianca Olver, Amy Lloyd, Peter Broderick, Nicola S. Russell, Cecile Janus, Alan Ashworth, Richard S. Houlston, Anthony J. Swerdlow

Blood (2012) 119 (4): 1029–1031.

https://doi.org/10.1182/blood-2011-10-383380

Published: 2012

Includes: Supplemental data

Journal Articles

Is Multiple Sclerosis a Risk for Hypercoagulation States or Breast Cancer? A Case Report and a Literature Review to Assess Options

Lisa Thomas, MD, Qi Shi, MD, Sathyanarayanan Ramakrishnan, MD, Jihua Jia, MD, Linda Thomas-Hemak, MD

Blood (2011) 118 (21): 4665.

https://doi.org/10.1182/blood.V118.21.4665.4665

Published: 2011

Journal Articles

BRCA1 and BRCA2 Nucleotide Variants in Young Women with Therapy Related Acute Myeloid Leukemia.

Michael G. Martin, MD, Meagan Jacoby, MD, Jin Shao, Elena Deych, PhD, Timothy Graubert, MD, Matthew J. Walter, MD

Blood (2009) 114 (22): 1102.

https://doi.org/10.1182/blood.V114.22.1102.1102

Published: 2009

Journal Articles

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party

Debra L. Friedman, Alicia Rovo, Wendy Leisenring, Anna Locasciulli, Mary E. D. Flowers, Andre Tichelli, Jean E. Sanders, H. Joachim Deeg, Gerard Socie

Blood (2008) 111 (2): 939–944.

https://doi.org/10.1182/blood-2007-07-099283

Published: 2008

Includes: Supplemental data

Journal Articles

Treatment Decisions for Young Women with Supra-Diaphragmatic, Limited-Stage Hodgkin Lymphoma: Exploration of Options Using a Markov Decision Analysis.

Lisa Hicks, Rebecca Dent, Ralph M. Meyer, David Naimark

Blood (2007) 110 (11): 369.

https://doi.org/10.1182/blood.V110.11.369.369

Published: 2007

Journal Articles

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors

Deirdre A. Hill, Ethel Gilbert, Graça M. Dores, Mary Gospodarowicz, Flora E. van Leeuwen, Eric Holowaty, Bengt Glimelius, Michael Andersson, Tom Wiklund, Charles F. Lynch, Mars van't Veer, Hans Storm, Eero Pukkala, Marilyn Stovall, Rochelle E. Curtis, James M. Allan, John D. Boice, Lois B. Travis

Blood (2005) 106 (10): 3358–3365.

https://doi.org/10.1182/blood-2005-04-1535

Published: 2005

Journal Articles

Is the Risk of Breast Cancer Increased after Hematopoietic Cell Transplantation?.

Debra L. Friedman, MD, MS, Wendy Leisenring, ScD, Jeffrey Schwartz, PhD, H. Joachim Deeg, MD

Blood (2004) 104 (11): 55.

https://doi.org/10.1182/blood.V104.11.55.55

Published: 2004

NARROW

Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma

Chronic Myeloid Leukemia Incidence Based Estimates of Hematopoietic Stem Cell Numbers per Person

Cancer in Heterozygote Carriers of Fanconi Anemia Genes

PALB2 Mutational Status in Haematopoeitic Malignancies - a Potential Therapeutic Target?

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Low Testosterone Levels Are Associated with Shorter Progression Free Survival in Multiple Myeloma

FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma

Is Multiple Sclerosis a Risk for Hypercoagulation States or Breast Cancer? A Case Report and a Literature Review to Assess Options

BRCA1 and BRCA2 Nucleotide Variants in Young Women with Therapy Related Acute Myeloid Leukemia.

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party

Treatment Decisions for Young Women with Supra-Diaphragmatic, Limited-Stage Hodgkin Lymphoma: Exploration of Options Using a Markov Decision Analysis.

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors

Is the Risk of Breast Cancer Increased after Hematopoietic Cell Transplantation?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only